However, the functional effects of mitochondrial receptors, particularly AT2 receptors, must be taken into account in the design of new therapeutic strategies, and especially in diseases associated with excessive oxidative stress such as PD, but also diabetes, obesity and most of the cardiovascular diseases. This evidence concerns the gene AGTR2 and obesity due to melanocortin 4 receptor deficiency.